Are proteasome inhibitors a panacea?

被引:0
|
作者
Wójcik, C [1 ]
机构
[1] Med Acad Warsaw, Dept Histol & Embryol, Inst Biostruct, PL-02004 Warsaw, Poland
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:192 / 192
页数:1
相关论文
共 50 条
  • [11] Farnesyl transferase inhibitors and proteasome inhibitors
    Johnston, SRD
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S87 - S87
  • [12] POTENT INHIBITORS OF PROTEASOME
    IQBAL, M
    CHATTERJEE, S
    KAUER, JC
    DAS, M
    MESSINA, P
    FREED, B
    BIAZZO, W
    SIMAN, R
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (13) : 2276 - 2277
  • [13] Macrocyclic Proteasome Inhibitors
    Krahn, D.
    Ottmann, C.
    Kaiser, M.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (33) : 5052 - 5060
  • [14] New Proteasome Inhibitors
    Orlowski, Robert Z.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S43 - S44
  • [15] Proteasome inhibitors Commentary
    Teicher, Beverly A.
    Tomaszewski, Joseph E.
    BIOCHEMICAL PHARMACOLOGY, 2015, 96 (01) : 1 - 9
  • [16] Proteasome inhibitors: Introduction
    Heuck, Christoph J.
    Shaughnessy, John D., Jr.
    SEMINARS IN HEMATOLOGY, 2012, 49 (03) : 193 - 195
  • [17] The ubiquitin proteasome system and efficacy of proteasome inhibitors in diseases
    Chitra, Selvarajan
    Nalini, Ganesan
    Rajasekhar, Gopalakrishnan
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (03) : 249 - 260
  • [18] EGFR activation and ERK survival signaling is triggered by proteasome inhibitors: implications for combining proteasome inhibitors with EGFR inhibitors
    Cusack, J.
    Wang, F.
    Sloss, C.
    Lu, R.
    Xia, L.
    EJC SUPPLEMENTS, 2006, 4 (12): : 56 - 56
  • [19] Proteasome Inhibitors with Photocontrolled Activity
    Hansen, Mickel J.
    Velema, Willem A.
    de Bruin, Gerjan
    Overkleeft, Herman S.
    Szymanski, Wiktor
    Feringa, Ben L.
    CHEMBIOCHEM, 2014, 15 (14) : 2053 - 2057
  • [20] Proteasome inhibitors as anticancer agents
    Gazzaroli, Giorgia
    Angeli, Andrea
    Giacomini, Arianna
    Ronca, Roberto
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2023, 33 (11) : 775 - 796